JanssenCarePath.com The  Janssen CarePath℠ Billing & Reimbursement infosource for U.S. Healthcare Professionals remicade.com simponiaria.com
simponi.com stelarainfo.com
FOR DEMONSTRATION PURPOSES ONLY


To get started, you need to complete a Business Associate Agreement (BAA)  or Patient Authorization (REMICADE®SIMPONI ARIA®SIMPONI®STELARA®).  You need to have this on file with us, as we cannot accept any information without an executed BAA or Patient Authorization on file. Then you can register to get an account. There is no charge for this Portal.


New User? Please Register.
 
Once you register and your account
is validated, both patient and provider
information will be available.
Please note that this is a secure site.

 
 
 

Registered User? Please Sign In.
 
User Name: *

   Password: *

NOTE: Password is case-sensitive.
Forgot your password? Click Here
 
 
Please read the full Prescribing Information, including Boxed Warnings, and Medication Guide for REMICADE®. Provide the Medication Guide to your patients and encourage discussion. Please read the full Prescribing Information, including Boxed Warnings, and Medication Guide for SIMPONI ARIA®. Provide the Medication Guide to your patients and encourage discussion. Please read the full Prescribing Information, including Boxed Warnings, and Medication Guide for SIMPONI®. Provide the Medication Guide to your patients and encourage discussion. Please read the full Prescribing Information and Medication Guide for STELARA®. Provide the Medication Guide to your patients and encourage discussion.

FOR DEMONSTRATION PURPOSES ONLY

Patient insurance benefit investigation is provided as a service by the support services administrator under contract for Janssen Biotech, Inc. In this regard, the support services administrator assists healthcare professionals in the determination of whether treatment could be covered by the applicable third-party payer based on coverage guidelines provided by the payer and patient information provided by the healthcare provider under appropriate authorization following the providers’ exclusive determination of medical necessity.

Importantly, insurance verification is the ultimate responsibility of the provider. Third-party reimbursement is affected by many factors. Therefore, the support services administrator, and Janssen Biotech, Inc., make no representation or guarantee that full or partial insurance reimbursement or any other payment will be available. This information is provided as an information service only. While the support services administrator tries to provide correct information, it and Janssen Biotech, Inc., make no representations or warranties, expressed or implied, as to the accuracy of the information. In no event shall the support services administrator, or Janssen Biotech, Inc., or its employees, or agents be liable for any damages resulting from or relating to the services. All providers and other users of this information agree that they accept responsibility for the use of this service.

Janssen Biotech, Inc., assumes no responsibility for, and does not guarantee, the quality, scope, or availability of the services including, but not limited to, reimbursement support services, patient education, and other support services. Each provider, not Janssen Biotech, Inc., is responsible for the services they provide. These support services have no independent value to providers apart from the product and are included within the cost of the product.

WARNING NOTICE: You are about to enter a private Web site that is restricted to authorized use by Janssen Biotech, Inc., and their authorized agents (“the Company”) for business purposes only. The actual or attempted unauthorized access, use, or modification of the Web site and its contents is strictly prohibited by the Company. Unauthorized users and/or unauthorized use are subject to criminal and/or civil penalties in accordance with applicable domestic and foreign laws. The use of this Web site may be monitored and recorded for administrative and security reasons. If such monitoring and/or recording reveals possible evidence of criminal activity, the Company may provide the monitored evidence of such activity to law enforcement officials. Access to this application from an untrusted workstation, including, but not limited to, cyber cafes and public kiosks, is prohibited.

Home  |   Overview  |   Insurance Coverage  |   Reimbursement  |   Patient Affordability  |   Support  |   Indications and Important Safety Information
FAQ  |   Janssen CarePath  |   Contact Us

By using this site you agree to our Legal Notice and Privacy Policy.
This site is published by Janssen Biotech, Inc., which is solely responsible for its contents. It is intended for residents of the United States and Puerto Rico only.
Third party trademarks used herein are trademarks of their respective owners.
© Janssen Biotech, Inc. 2016. This page was last updated on  Friday, June 24, 2016.